Source:http://linkedlifedata.com/resource/pubmed/id/20226764
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-4-12
|
pubmed:abstractText |
The insulin receptor substrate (IRS) proteins are major substrates of both insulin receptor and insulin-like growth factor (IGF)-I receptor tyrosine kinases. Previously, we reported that IRS-3 is localized to both cytosol and nucleus, and possesses transcriptional activity. In the present study, we identified Bcl-3 as a novel binding protein to IRS-3. Bcl-3 is a nuclear protein, which forms a complex with the homodimer of p50 NF-kappaB, leading to enhancement of transcription through p50 NF-kappaB. We found that Bcl-3 interacts with the pleckstrin homology domain and the phosphotyrosine binding domain of IRS-3, and that IRS-3 interacts with the ankyrin repeat domain of Bcl-3. In addition, IRS-3 augmented the binding activity of p50 to the NF-kappaB DNA binding site, as well as the tumor necrosis factor (TNF)-alpha-induced transcriptional activity of NF-kappaB. Lastly, IRS-3 enhanced NF-kappaB-dependent anti-apoptotic gene induction and consequently inhibited TNF-alpha-induced cell death. This series of results proposes a novel function for IRS-3 as a transcriptional regulator in TNF-alpha signaling, distinct from its function as a substrate of insulin/IGF receptor kinases.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Insulin Receptor Substrate Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B p50 Subunit,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/proto-oncogene protein bcl-3
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1090-2104
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
9
|
pubmed:volume |
394
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
697-702
|
pubmed:meshHeading |
pubmed-meshheading:20226764-Animals,
pubmed-meshheading:20226764-Apoptosis,
pubmed-meshheading:20226764-COS Cells,
pubmed-meshheading:20226764-Cercopithecus aethiops,
pubmed-meshheading:20226764-Humans,
pubmed-meshheading:20226764-Insulin Receptor Substrate Proteins,
pubmed-meshheading:20226764-NF-kappa B p50 Subunit,
pubmed-meshheading:20226764-Proto-Oncogene Proteins,
pubmed-meshheading:20226764-Transcription, Genetic,
pubmed-meshheading:20226764-Transcription Factors,
pubmed-meshheading:20226764-Transcriptional Activation,
pubmed-meshheading:20226764-Tumor Necrosis Factor-alpha,
pubmed-meshheading:20226764-Two-Hybrid System Techniques
|
pubmed:year |
2010
|
pubmed:articleTitle |
Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity.
|
pubmed:affiliation |
Departments of Animal Sciences and Applied Biological Chemistry, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|